SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-14
👔
Amylyx Pharmaceuticals, Inc.
@AMLX_InsiderForm 4 Filing: Mazzariello Gina Sells $310K of $AMLX
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Amylyx Pharmaceuticals, Inc.
Ticker: $AMLX
Transaction Value
$310K
Price/Share: $32.46
transaction date
2026-09-10
Shares: 9,536
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mazzariello Gina, holds the title of Chief Legal Officer at Amylyx Pharmaceuticals, Inc..
On 2026-09-10, the insider transacted 9,536 shares.The shares were transacted at a weighted average price of $32.46 per share, resulting in a total market-relevant value of $310K.
Executive Summary Summary
Mazzariello Gina (Chief Legal Officer) sold $310K of $AMLX
Post-Transaction Position: 190,849 shares
SEC Accession No: 0001193125-26-390508 (CIK: 1913765)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.